Contact
Menu
 Search icon

 

 

About Diabetic Foot Ulcers

By the year 2025, there will be 300 million diabetic patients worldwide.1 KCI (An Acelity Company) provides a comprehensive range of solutions that can help speed healing for diabetic ulcers.

Diabetic patients have a lifetime risk between 15% and 25% of developing a diabetic foot ulcer.1, 3
  • The number of new DFUs in the UK was estimated to be 120,000 in 2017.2 
  • 17% of all diabetic foot wounds will result in amputation within the first year of diagnosis2
  • Only 35% of DFU’s heal within the 12 months (mean time to healing 4.4 months).2 
  • It is estimated that DFU patients cost the NHS approximately £931m in the first 12 months from onset. 2

The Science Behind Our Products

Our solutions are built on a deep understanding of wound healing and supported by a large body of clinical evidence.

Diabetic foot ulceration

 

Diabetic foot ulcertation e-learning module

 

It is estimated that one in four people with diabetes will have a diabetic foot ulcer during their lives, as a result of a combination of diabetes-related complications. Development of infection in a diabetic foot ulcer may be limb- or life-threatening. However, with good diabetes management and regular assessment this can be prevented.
 

Module details

Why It Matters

Diabetes is the leading cause of non-traumatic lower extremity amputations in the UK. 17% of all diabetic foot wounds will result in amputation.2 Every year, 12,000 people undergo an amputation in the UK as a result of diabetes.2 Ulcers form due to a combination of factors, such as lack of feeling in the foot, poor circulation, foot deformities, irritation (such as friction or pressure) and trauma. Fortunately, as research shows, the development of a foot ulcer is preventable.4

Explore Products for Diabetic Foot Ulcers

At KCI, we take DFUs seriously. Our portfolio of Advanced Wound Dressings and Negative Pressure Wound Therapy are designed to offer you the right solution at the right stage of healing process.

V.A.C.® Therapy

KCI provides a wide range of Negative Pressure Wound Therapy systems for hospital, community or home treatment. Since its launch in 1995, V.A.C.® Therapy has changed the way wounds are treated. Backed by more published clinical evidence than any other Negative Pressure Wound Therapy Systems, V.A.C.® Therapy has become the clinician’s treatment of choice for more than 10 million wounds worldwide.*
 *As of 2016. KCI data on file.

V.A.C.® Therapy promotes wound healing through the application of negative (vacuum) pressure at the wound site. This helps to draw wound edges together, remove infectious materials and actively promote granulation.
 

Advanced Wound Dressings

Every wound is different. That is why KCI provides a comprehensive range of advanced wound dressings to help address each wound’s specific needs. Our product portfolio is the result of over 80 years of experience in developing innovative solutions to help you manage wounds towards healing.
 
A number of our advanced wound dressings such as PROMOGRAN™ Matrix and PROMOGRAN PRISMA™ Matrix offer antimicrobial benefits to help infected wounds, while our other advanced wound dressings such as ADAPTIC™ Non-Adhering Dressing serve as a gentle silicone wound contact layer. TIELLE™ Hydropolymer Dressings with LIQUALOCK™ Advanced Absorption Technology offer moist wound healing which can be conducive to wound healing.
 

Clinician Resources

Education is key to promoting quality of care, particularly when it involves the healthcare community. Our instructional programmes – from professional training to continuing education – provide a continuum designed to improve skills and enrich knowledge across all healthcare settings.

Learn more

A Patient’s Perspective

Patients help others by sharing their stories on how Acelity products have helped them.

Patients’ Stories
 
References
  1. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005 Jan 12;293(2):217-28. Review. 
  2. Guest J, Singh H, Vowden P. Potential cost cost-effectiveness of using a collagen dressing in managing diabetic foot ulcers in the UK. Accepted for publication International Wound Journal 2017.
  3. Mayfield JA, Reiber GE, Sanders LJ, et al. Preventive foot care in people with diabetes. Diabetes Care. 1998 Dec;21(12):2161-77. Review.
  4. American Podiatric Medical Association:  www.apma.org/Learn/FootHealth.cfm?ItemNumber=981